What is Veeva?
Veeva Systems Inc. is a prominent provider of cloud-based software solutions tailored for the life sciences industry. Operating globally, the company offers a comprehensive suite of products, including Veeva Commercial Cloud for customer relationship management and Veeva Vault, an enterprise content management platform. These solutions empower pharmaceutical, biotechnology, and other healthcare organizations to streamline sales, marketing, research, and development processes. Veeva also provides essential data solutions and services, such as master data management and key opinion leader identification, to enhance operational efficiency and strategic decision-making. Originally founded as Verticals onDemand, Inc. in 2007, the company rebranded to Veeva Systems Inc. in April 2009, signaling its focused commitment to the life sciences vertical.
How much funding has Veeva raised?
Veeva has raised a total of $258M across 4 funding rounds:
Series A
$3M
Series B
$4M
Stock Offering
$216M
Stock Offering
$35M
Series A (2007): $3M with participation from Undisclosed
Series B (2008): $4M led by Emergence Capital Partners
Stock Issuance/Offering (2013): $216M supported by Undisclosed
Stock Issuance/Offering (2014): $35M featuring Undisclosed
Key Investors in Veeva
Emergence Capital Partners
Emergence Capital Partners is a venture capital firm recognized for its focus on early-stage enterprise companies, aiming to be a valuable partner in transforming how businesses operate.
Undisclosed Investors
Undisclosed Investors
What's next for Veeva?
With a history of substantial capital raises, including its most recent strategic investment, Veeva Systems Inc. is well-positioned for continued expansion and technological advancement. The company's focus on enterprise-level solutions for the highly regulated life sciences sector suggests a trajectory of deepening market penetration and product development. Future growth is likely to be driven by enhancing its cloud-based offerings, expanding its data solutions, and potentially exploring new therapeutic areas or adjacent markets. The consistent backing indicates strong investor confidence in Veeva's business model and its ability to navigate the complexities of the life sciences industry, paving the way for sustained innovation and market leadership.
See full Veeva company page
